NMR spectroscopy is an advantageous tool for fragment-based lead discovery because it combines high sensitivity and robustness to loose fragment binders with unique structural resolution and throughput. Favourable applications include screening against shallow binding pockets (such as protein-protein interactions) and side-pockets outside the highly conserved active centre of the major target classes (such as protein kinases and proteases) to gain selectivity. A set of protein-and ligand-detected NMR assay techniques allows for the identification of novel chemotypes and the determination of protein-ligand structures for soluble target proteins of up to 100kD.
for simpler synthesis protocols. The improved binding efficiency of fragments -defined as the free energy of binding divided by the number of heavy atoms or MWresults from their additional degrees of rotational and translational freedom, allowing for an optimal positioning within the protein pocket ( Figure 1A ). By contrast, identical sub-structures in higher MW compound collections are constrained in their freedom of positioning by the presence of bulky substituents ( Figure 1B ).
ADVANTAGES OF NMR FOR FRAGMENT SCREENING
Fragments exhibit significantly weaker binding affinities, typically in the micromolar to millimolar range, than compounds of higher MW. Hence, exceptionally sensitive and robust detection technologies, such as nuclear magnetic resonance (NMR) spectroscopy, are required for assaying fragment binding to target proteins. In the absence of structural information, fragment-tolead optimisation is more challenging for loose fragment hits than for tightly binding hits because derivatives of fragments are more flexible to change their binding geometry, thereby showing potentially misleading structure activity relationships (SAR). Therefore 3D structural information about the binding sites of fragments, which are obtainable from NMR assays for tens to hundreds of derivatives, strongly assists SAR studies. This unique combination of high sensitivity to loosely binding fragments and medium-to highthroughput for binding site determination renders NMR an advantageous fragment screening technique, as evidenced by numerous successful applications of NMRscreening in the literature (3). Figure 3B ).
In the ligand-detected SaturationTransfer-Difference (STD) experiment, the hydrogen atoms of the target protein (usually the methyl protons) are selectively excited. This magnetisation diffuses across the protein and onto bound ligands, whereas non-binding ligands are not affected. By recording 1D 
STRUCTURAL INFORMATION FROM LIGAND-DETECTED NMR ASSAYS
Structural information about the binding site of fragments can be obtained by running WaterLOGSY or STD NMR assays in the presence of competitor or reporter compounds. For example, to discriminate between binding to the catalytic and allosteric sites of a given protein, a competitor -whose binding site is known -can be used to displace a fragment binder. Displacement is monitored by
PROTEIN-DETECTED NMR-SCREENING
The best known and structurally most informative NMRscreening technique is the SAR-by-NMR method pioneered by Abbott Laboratories. It senses local chemical shift perturbations (CSPs) for the NMR signals of the protein when a ligand binds, which led to the name 'Protein-Detected NMR-Screening'. The method uniquely allows direct determination of the binding site of the ligand from the local cluster of typically 5-10 CSPs surrounding a fragment binder (Figure 2 ). Numerous publications show that this method is amenable to ligand molecular weights ranging from minute Mg 2+ cations to macromolecular proteins or nucleic acids. Likewise, ligand affinities ranging from two digit millimolar down to subnanomolar Kd values are robustly detected.
By using powerful isotope labelling strategies and relaxation-optimised NMR pulse programmes, soluble proteins of up to 50kD can be studied. This limit includes the active domains of many therapeutically relevant target proteins. More serious limitations arise from the necessity for stable isotope labelling with 
LIGAND-DETECTED NMR-SCREENING
Ligand-detected NMR-screening constitutes the ideal back-up technique for target proteins that are not amenable to protein-detected NMR-screening due to MW >50kD, inaccessibility to isotope labelling, low expression yields or low solubility of <30µM. According to their name, liganddetected methods measure the 1 H NMR signals of the small molecule ligand, which differ in their intensity, relaxation properties and sign between bound and unbound ligands. Usually ligands are assayed in 10-to 50-fold excess over protein, which yields improved signal-tonoise but requires that ligands bind in the fast exchange regime on the NMR time-scale. This fast exchange requirement limits ligand-detected NMR assays to an affinity window between approximately 0.1µM and 10mM, which perfectly covers the typical affinity range of fragment binders, but precludes ligands with high potency and slow off-rates. Moreover, atomic resolution structures of proteinligand complexes can be determined by using the STD-NMR assay, provided that the 3D structure of the protein is known (4) . Distance restraints between protein and ligand are obtained by recording STD-NMR spectra on four to six amino acid type labelled and perdeuterated protein samples in the presence of the ligand of interest. Combining this set of distance restraints during structure calculation results in high resolution protein-ligand complexes. Thus, STD-NMR can yield complex structures for proteinligand pairs not amenable to co-crystallisation or soaking.
WATERLOGSY AND STD NMR-SCREENING

LEAD DISCOVERY FOR PROTEIN-PROTEIN INTERACTION TARGETS
Target proteins with shallow binding pockets, such as protein-protein interactions, require screening technologies with enhanced sensitivity for loose binders and excellent binding efficiency because conventional screening assays usually fail for such targets. By contrast, NMR-fragment-screening routinely identifies such weak fragment binders which better fit into such pockets. In addition, the structural information guides the hit-tolead process in which the chemical substructures of fragments binding next to each other are merged into a larger, more potent and more specific compound. In the absence of structural data, a much larger and often prohibitive number of derivatives has to be synthesised for each fragment hit. In-house research in collaboration with the academic group of Professor Hartmut Oschkinat (Forschungsinstitut für Molekulare Pharmakologie, Berlin) supports this concept (5) . The PDZ domain of the human protein AF6 mediates protein-protein interactions through a shallow groove that binds to the C-terminal 4 to 7 residues of membrane receptors and ion channels (Figure 4 , page 50). The affinity to natural 6-residue peptide mimetics is in the weak three digit micromolar range indicating low drugability. However, by using protein-detected NMR-screening, three chemically distinct classes of fragment hits can be identified. One chemical class was synthetically optimised with support from the structural binding site data. The high resolution 3D structure of the complex between the PDZ domain and the best derivative confirms binding to the active site, and guides further hit-to-lead chemistry.
FRAGMENT-SCREENING FOR SELECTIVE LEADS
Lead structures for the major target classes -such as protein kinases, protein phosphatases and proteasesfrequently suffer from insufficient selectivity for the single targeted protein, because enzymatic pockets are similar within a class. This selectivity problem can be addressed by using NMR-fragment-screening to find fragment binders to protein sub-pockets surrounding the enzymatic site. Such sub-pockets are usually not conserved across the target class, thus allowing for interactions selective to the targeted protein.
A successful application of this concept is the generation of highly selective leads for the challenging anti-diabetes target, protein-tyrosine-phosphatase 1b (PTP-1b) (6) . By protein-detected NMR-screening, novel fragment hits to a neighbouring sub-pocket were identified and chemically linked to the known core lead structure in the enzymatic pocket. The resulting new lead structure shows better selectivity over side effect-relevant phosphatases than numerous other PTP-1b inhibitors disclosed at that time.
Dependent on the molecular weight and accessibility of the target protein to isotope labelling, any of the previously described NMR-fragment-screening methods can be applied to search for sub-pocket binders. The common advantage of all NMR methods stems from the fact that loose binders to sub-pockets outside the enzymatic cavity can be detected, which is impossible by biochemical assays. 
NOVEL CHEMOTYPES FOR LIBRARY DESIGN
